Instituto Oftalmologico Fernandez-Vega S.L.

Research at Instituto Oftalmologico Fernandez-Vega S.L. focuses on ophthalmology, with studies spanning common and sight-threatening eye diseases. The trials are designed to assess new treatments, improve visual outcomes, and better understand how to manage chronic retinal and corneal conditions.

• Age-related macular degeneration, including neovascular and wet forms, with research aimed at improving vision and controlling disease activity
• Dry eye disease, evaluating therapies intended to relieve symptoms and support the eye surface
• Corneal disorders such as Fuchs endothelial corneal dystrophy, persistent corneal epithelial defects, and neurotrophic keratopathy, with a focus on healing and corneal repair
• Polypoidal choroidal vasculopathy and subretinal hyperreflective material, studying approaches that may improve retinal structure and visual function

The site’s clinical research reflects a strong interest in both retinal and corneal disease, combining efforts to test innovative eye treatments with studies that look at long-term safety, effectiveness, and patient benefit.

This research area centers on neovascular age-related macular degeneration and related macular conditions. Studies here are evaluating whether newer therapies can improve best-corrected visual acuity, reduce treatment burden, and maintain vision over time in patients with chronic retinal disease.

• Neovascular age-related macular degeneration, testing treatment strategies that aim to preserve sight and control fluid-related damage
• Polypoidal choroidal vasculopathy, assessing effectiveness and durability of treatment in a distinct macular disorder
• Subretinal hyperreflective material, exploring whether therapy can help resolve retinal changes linked to vision loss
• Surabgene lomparvovec and ranibizumab-based approaches, comparing long-term control of disease and injection burden

These trials support the development of better options for patients living with chronic macular disease, especially where sustained vision improvement and fewer treatments are important goals.

The corneal program at this site includes research on Fuchs endothelial corneal dystrophy, persistent corneal epithelial defects, neurotrophic keratopathy, and dry eye disease. The main purpose is to evaluate therapies that may promote healing, improve comfort, and strengthen the eye’s surface.

• Fuchs endothelial corneal dystrophy, studying treatment options that may improve visual recovery after corneal procedures
• Persistent corneal epithelial defects, testing whether new eye treatments can support lasting corneal re-epithelialization
• Neurotrophic keratopathy, examining therapies intended to enhance corneal healing and safety
• Dry eye disease, evaluating eye drops designed to reduce irritation and improve ocular surface health

Overall, the work in this area is aimed at helping patients with difficult-to-treat surface disease by finding options that improve healing and day-to-day eye comfort.